Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


28.01.2019

1 Am J Kidney Dis
2 Am J Nephrol
1 Atherosclerosis
1 Biochem Biophys Res Commun
3 BMJ
1 Br J Ophthalmol
11 Diabet Med
7 Diabetes
21 Diabetes Care
2 Diabetes Educ
2 Diabetes Obes Metab
3 Diabetologia
1 Eur J Endocrinol
1 J Biol Chem
3 J Clin Endocrinol Metab
2 J Diabetes Complications
1 Kidney Int
2 Lancet
1 Lancet Diabetes Endocrinol
2 Med J Aust
1 Nature
1 Nutr Metab (Lond)
5 Pediatr Diabetes
5 PLoS One
1 Retina
1 WMJ


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Kidney Dis

  1. ROSSING P, Frimodt-Moller M, Persson F
    Increasing ESKD in Diabetes in the Land Down Under: What Can Be Done, We Must Wonder.
    Am J Kidney Dis. 2019 Jan 18. pii: S0272-6386(18)31122.
    PubMed     Text format    


    Am J Nephrol

  2. RUGGENENTI P, Remuzzi G
    Albuminuria Regression in Diabetes: A Therapeutic Target for Nephro- and Cardio-Protection, in Clinics and Research.
    Am J Nephrol. 2019;49:143-145.
    PubMed     Text format    

  3. ANYANWAGU U, Donnelly R, Idris I
    Albuminuria Regression and All-Cause Mortality among Insulin-Treated Patients with Type 2 Diabetes: Analysis of a Large UK Primary Care Cohort.
    Am J Nephrol. 2019;49:146-155.
    PubMed     Text format     Abstract available


    Atherosclerosis

  4. WAKE M, Oh A, Onishi Y, Guelfucci F, et al
    Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan.
    Atherosclerosis. 2018;282:19-28.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  5. YANG J, Zhao Z, Yuan H, Ma X, et al
    The mechanisms of glycemic variability accelerate diabetic central neuropathy and diabetic peripheral neuropathy in diabetic rats.
    Biochem Biophys Res Commun. 2019 Jan 17. pii: S0006-291X(18)32866.
    PubMed     Text format     Abstract available


    BMJ

  6. MAYOR S
    Delivering diabetes targets: five minutes with . . . Sam Everington.
    BMJ. 2019;364:l229.
    PubMed     Text format    

  7. SKOVENBORG E
    Shift work and diabetes: alcohol consumption as a risk factor.
    BMJ. 2019;364:l177.
    PubMed     Text format    

  8. MANFREDINI R, Cappadona R, Fabbian F
    Nurses, shift work, and diabetes: should late chronotype be considered as a risk factor?
    BMJ. 2019;364:l178.
    PubMed     Text format    


    Br J Ophthalmol

  9. ZENG Y, Cao D, Yu H, Yang D, et al
    Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy.
    Br J Ophthalmol. 2019 Jan 23. pii: bjophthalmol-2018-313582.
    PubMed     Text format     Abstract available


    Diabet Med

  10. BOULTON AJM
    The 2017 Banting Memorial Lecture The diabetic lower limb - a forty year journey: from clinical observation to clinical science.
    Diabet Med. 2019 Jan 19. doi: 10.1111/dme.13901.
    PubMed     Text format     Abstract available

  11. PANTALONE KM, Misra-Hebert AD, Hobbs TM, Ji X, et al
    Intensification patterns and the probability of HbA1c goal attainment in Type 2 diabetes mellitus: real-world evidence for the concept of 'intensification inertia'.
    Diabet Med. 2019 Jan 17. doi: 10.1111/dme.13900.
    PubMed     Text format     Abstract available

  12. PARSONS SN, Luzio SD, Harvey JN, Bain SC, et al
    Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial.
    Diabet Med. 2019 Jan 17. doi: 10.1111/dme.13899.
    PubMed     Text format     Abstract available

  13. THAWARE PK, Patterson CC, Young IS, Casey C, et al
    Clinical utility of ultrasonography-measured visceral adipose tissue depth as a tool in early pregnancy screening for gestational diabetes: a proof-of-concept study.
    Diabet Med. 2019 Jan 22. doi: 10.1111/dme.13906.
    PubMed     Text format     Abstract available

  14. TONNIES T, Rockl S, Hoyer A, Heidemann C, et al
    Projected number of people with diagnosed Type 2 diabetes in Germany in 2040.
    Diabet Med. 2019 Jan 19. doi: 10.1111/dme.13902.
    PubMed     Text format     Abstract available

  15. BROOKS A, Chakera AJ
    The challenge of managing Type 1 diabetes in frail older people.
    Diabet Med. 2019 Jan 21. doi: 10.1111/dme.13904.
    PubMed     Text format     Abstract available

  16. COETZEE A, van de Vyver M, Hoffmann M, Hall DR, et al
    A comparison between point-of-care testing and venous glucose determination for the diagnosis of diabetes mellitus 6-12 weeks after gestational diabetes.
    Diabet Med. 2019 Jan 21. doi: 10.1111/dme.13903.
    PubMed     Text format     Abstract available

  17. ZGHEBI SS, Panagioti M, Rutter MK, Ashcroft DM, et al
    Assessing the severity of Type 2 diabetes using clinical data-based measures: a systematic review.
    Diabet Med. 2019 Jan 22. doi: 10.1111/dme.13905.
    PubMed     Text format     Abstract available

  18. GROENEVELD Y, Tavenier D, Blom JW, Polak BCP, et al
    Incidence of sight-threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review.
    Diabet Med. 2019 Jan 24. doi: 10.1111/dme.13908.
    PubMed     Text format     Abstract available

  19. VOS RC, van Heusden L, Eikelenboom NWD, Rutten GEHM, et al
    Theory-based diabetes self-management education with pre-selection of participants: a randomized controlled trial with 2.5 years' follow-up (ELDES Study).
    Diabet Med. 2019 Jan 24. doi: 10.1111/dme.13907.
    PubMed     Text format     Abstract available

  20. MOSER O, Eckstein ML, Mueller A, Birnbaumer P, et al
    Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial.
    Diabet Med. 2019 Jan 24. doi: 10.1111/dme.13909.
    PubMed     Text format     Abstract available


    Diabetes

  21. HIPPICH M, Beyerlein A, Hagopian WA, Krischer JP, et al
    Genetic Contribution to the Divergence in Type 1 Diabetes Risk Between Children From the General Population and Children From Affected Families.
    Diabetes. 2019 Jan 17. pii: db18-0882. doi: 10.2337/db18-0882.
    PubMed     Text format     Abstract available


  22. In This Issue of Diabetes.
    Diabetes. 2019;68:237-238.
    PubMed     Text format    

  23. KOWLURU RA
    Mitochondrial Stability in Diabetic Retinopathy: Lessons Learned From Epigenetics.
    Diabetes. 2019;68:241-247.
    PubMed     Text format     Abstract available

  24. ALICIC RZ, Neumiller JJ, Johnson EJ, Dieter B, et al
    Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease.
    Diabetes. 2019;68:248-257.
    PubMed     Text format     Abstract available


  25. Statement of Retraction. Francesco Oriente, Salvatore Iovino, Serena Cabaro, Angela Cassese, Elena Longobardi, Claudia Miele, Paola Ungaro, Pietro Formisano, Francesco Blasi, and Francesco Beguinot. Prep1 Controls Insulin Glucoregulatory Function in L
    Diabetes. 2019;68:465-466.
    PubMed     Text format    

  26. SYREENI A, Sandholm N, Cao J, Toppila I, et al
    Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes.
    Diabetes. 2019 Jan 23. pii: db18-0573. doi: 10.2337/db18-0573.
    PubMed     Text format     Abstract available

  27. FABBRI M, Frixou M, Degano M, Fousteri G, et al
    Type 1 Diabetes in STAT Protein Family Mutations: Regulating the Th17/Treg Equilibrium and Beyond.
    Diabetes. 2019;68:258-265.
    PubMed     Text format     Abstract available


    Diabetes Care


  28. In This Issue of Diabetes Care.
    Diabetes Care. 2019;42:179-180.
    PubMed     Text format    

  29. ONENGUT-GUMUSCU S, Chen WM, Robertson CC, Bonnie JK, et al
    Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score.
    Diabetes Care. 2019 Jan 18. pii: dc18-1727. doi: 10.2337/dc18-1727.
    PubMed     Text format     Abstract available

  30. NANDITHA A, Snehalatha C, Satheesh K, Susairaj P, et al
    Secular TRends in DiabEtes in India (STRiDE-I): Change in Prevalence in Ten Years Among Urban and Rural Populations in Tamil Nadu.
    Diabetes Care. 2019 Jan 18. pii: dc18-1559. doi: 10.2337/dc18-1559.
    PubMed     Text format     Abstract available

  31. SAITO D, Oikawa Y, Yano Y, Ikegami Y, et al
    Detailed Time Course of Decline in Serum C-Peptide Levels in Anti-Programmed Cell Death-1 Therapy-Induced Fulminant Type 1 Diabetes.
    Diabetes Care. 2019 Jan 18. pii: dc18-1673. doi: 10.2337/dc18-1673.
    PubMed     Text format    

  32. CALLAWAY LK, McIntyre HD, Barrett HL, Foxcroft K, et al
    Probiotics for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Women: Findings From the SPRING Double-blind Randomized Controlled Trial.
    Diabetes Care. 2019 Jan 18. pii: dc18-2248. doi: 10.2337/dc18-2248.
    PubMed     Text format     Abstract available

  33. KALSCHEUER H, Seufert J, Lanzinger S, Rosenbauer J, et al
    Event Rates and Risk Factors for the Development of Diabetic Ketoacidosis in Adult Patients With Type 1 Diabetes: Analysis From the DPV Registry Based on 46,966 Patients.
    Diabetes Care. 2019 Jan 17. pii: dc18-1160. doi: 10.2337/dc18-1160.
    PubMed     Text format    

  34. LOWE WL JR, Scholtens DM, Kuang A, Linder B, et al
    Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Gestational Diabetes and Childhood Glucose Metabolism.
    Diabetes Care. 2019 Jan 17. pii: dc18-1646. doi: 10.2337/dc18-1646.
    PubMed     Text format     Abstract available

  35. SHARP SA, Rich SS, Wood AR, Jones SE, et al
    Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis.
    Diabetes Care. 2019;42:200-207.
    PubMed     Text format     Abstract available

  36. RIDDLE MC
    Diabetes Care in 2019-Who, Why, What, and How?
    Diabetes Care. 2019;42:181-182.
    PubMed     Text format    

  37. KAHN SE, Templin AT, Hull RL, Verchere CB, et al
    Probing the Meaning of Persistent Propeptide Release in Type 1 Diabetes.
    Diabetes Care. 2019;42:183-185.
    PubMed     Text format    

  38. PURNELL JQ, Wolfe BM
    Bariatric/Metabolic Surgery for Diabetes: Lessons From the Past and Present.
    Diabetes Care. 2019;42:186-188.
    PubMed     Text format    

  39. LI X, Meng X, Gao X, Pang X, et al
    Erratum. Elevated Serum Xanthine Oxidase Activity Is Associated With the Development of Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care 2018;41;884-890.
    Diabetes Care. 2019 Jan 23. pii: dc19-er03a. doi: 10.2337.
    PubMed     Text format    

  40. VERMA S, Mazer CD, Bhatt DL, Raj SR, et al
    Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial.
    Diabetes Care. 2019 Jan 23. pii: dc18-1959. doi: 10.2337/dc18-1959.
    PubMed     Text format    

  41. SKINNER SC, Diaw M, Pialoux V, Mbaye MN, et al
    Erratum. Increased prevalence of type 2 diabetes-related complications in combined type 2 diabetes and sickle cell trait. Diabetes Care 2018;41:2595-2602.
    Diabetes Care. 2019 Jan 23. pii: dc19-er03b. doi: 10.2337.
    PubMed     Text format    

  42. TONNEIJCK L, Smits MM, Muskiet MHA, Hoekstra T, et al
    Erratum. Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 2016;39:2042-2050.
    Diabetes Care. 2019 Jan 23. pii: dc19-er03. doi: 10.2337.
    PubMed     Text format    

  43. MATHEW AV, Pennathur S
    Response to Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431-2437.
    Diabetes Care. 2019;42:e26-e27.
    PubMed     Text format    

  44. HOLZER M, Marsche G
    Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431-2437.
    Diabetes Care. 2019;42:e25.
    PubMed     Text format    

  45. GALINDO RJ, Zambrano C, Vellanki P
    Comment on Desai et al. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 2018;41:1631-1638.
    Diabetes Care. 2019;42:e24.
    PubMed     Text format    

  46. BUCHWALD H, Buchwald JN
    Metabolic (Bariatric and Nonbariatric) Surgery for Type 2 Diabetes: A Personal Perspective Review.
    Diabetes Care. 2019;42:331-340.
    PubMed     Text format     Abstract available

  47. CEROLSALETTI K, Hao W, Greenbaum CJ
    Genetics Coming of Age in Type 1 Diabetes.
    Diabetes Care. 2019;42:189-191.
    PubMed     Text format    

  48. MULLIN B, Cervantes BS, Billimek J
    Material Need Insecurity and Its Concurrent Barriers to Diabetes Management Among Low-Income Latino Adults Receiving Medical Care.
    Diabetes Care. 2019 Jan 23. pii: dc18-1583. doi: 10.2337/dc18-1583.
    PubMed     Text format    


    Diabetes Educ

  49. GEE JP, Scarbrough J, Bowker D, Keller T, et al
    Diabetes Educators Beliefs About Patient Self-Management and Strategies Used to Support Persons With Diabetes.
    Diabetes Educ. 2019 Jan 18:145721718825356. doi: 10.1177/0145721718825356.
    PubMed     Text format     Abstract available

  50. APONTE J
    Demographics, A1C Testing, and Medication Use of Mexican Americans and Mexicans With Diabetes.
    Diabetes Educ. 2019 Jan 18:145721718825354. doi: 10.1177/0145721718825354.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  51. ZOBEL EH, von Scholten BJ, Goldman B, Persson F, et al
    Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: individual effects of treatment.
    Diabetes Obes Metab. 2019 Jan 20. doi: 10.1111/dom.13638.
    PubMed     Text format     Abstract available

  52. CHARYTAN DM, Solomon SD, Ivanovich P, Remuzzi G, et al
    Metformin Use and Cardiovascular Events in Patients with Type 2 Diabetes and Chronic Kidney Disease.
    Diabetes Obes Metab. 2019 Jan 22. doi: 10.1111/dom.13642.
    PubMed     Text format     Abstract available


    Diabetologia

  53. DUNNE JL, Richardson SJ, Atkinson MA, Craig ME, et al
    Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes.
    Diabetologia. 2019 Jan 23. pii: 10.1007/s00125-019-4811.
    PubMed     Text format     Abstract available

  54. READ SH, Fischbacher CM, Colhoun HM, Gasevic D, et al
    Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015.
    Diabetologia. 2019 Jan 17. pii: 10.1007/s00125-018-4796.
    PubMed     Text format     Abstract available

  55. XIA MF, Lin HD, Chen LY, Wu L, et al
    The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes.
    Diabetologia. 2019 Jan 23. pii: 10.1007/s00125-018-4805.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  56. XU G, You D, Wong L, Duan D, et al
    Risk of all-cause and CHD mortality in women versus men with type 2 diabetes: a systematic review and meta-analysis.
    Eur J Endocrinol. 2019 Jan 1. pii: EJE-18-0792.R1. doi: 10.1530/EJE-18-0792.
    PubMed     Text format     Abstract available


    J Biol Chem

  57. MICHAEL ES, Covic L, Kuliopulos A
    TAAR1 promotes anti-diabetic signaling in insulin-secreting cells.
    J Biol Chem. 2019 Jan 22. pii: RA118.005464. doi: 10.1074/jbc.RA118.005464.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  58. MAKINEN M, Loyttyniemi E, Koskinen M, Vaha-Makila M, et al
    Serum 25-Hydroxyvitamin D Concentrations at Birth in Children Screened for HLA-DQB1 Conferred Risk for Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Jan 16. pii: 5289723. doi: 10.1210/jc.2018-02094.
    PubMed     Text format     Abstract available

  59. SHALIMOVA A, Graff B, Gasecki D, Wolf J, et al
    Cognitive Dysfunctions in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Jan 18. pii: 5290155. doi: 10.1210/jc.2018-01315.
    PubMed     Text format     Abstract available

  60. VAVANIKUNNEL J, Charlier S, Becker C, Schneider C, et al
    Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study.
    J Clin Endocrinol Metab. 2019 Jan 16. pii: 5244186. doi: 10.1210/jc.2018-01879.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  61. THETHI TK, Batuman V
    Challenging the conventional wisdom on diabetic nephropathy: Is microalbuminuria the earliest event?
    J Diabetes Complications. 2018 Dec 14. pii: S1056-8727(18)31325.
    PubMed     Text format     Abstract available

  62. NORTON EB
    Altered responses to pneumococcal vaccination in an elderly diabetic Japanese vaccine trial: The risk of concurrent vaccination strategies.
    J Diabetes Complications. 2018 Dec 21. pii: S1056-8727(18)31363.
    PubMed     Text format    


    Kidney Int

  63. STARUSCHENKO A
    TRPC6 in diabetic kidney disease: good guy or bad guy?
    Kidney Int. 2019;95:256-258.
    PubMed     Text format     Abstract available


    Lancet

  64. THE LANCET
    Modernising the NHS: leading the way with diabetes.
    Lancet. 2019;393:200.
    PubMed     Text format    

  65. STEDMAN M, Lunt M, Livingston M, Fryer AA, et al
    The costs of drug prescriptions for diabetes in the NHS.
    Lancet. 2019;393:226-227.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  66. TAY J, de Bock MI, Mayer-Davis EJ
    Low-carbohydrate diets in type 2 diabetes.
    Lancet Diabetes Endocrinol. 2019 Jan 15. pii: S2213-8587(18)30368.
    PubMed     Text format    


    Med J Aust

  67. ALBARQOUNI L, Doust JA, Magliano D, Barr EL, et al
    External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Med J Aust. 2019 Jan 18. doi: 10.5694/mja2.12061.
    PubMed     Text format     Abstract available

  68. TITMUSS A, Davis EA, Brown A, Maple-Brown LJ, et al
    Emerging diabetes and metabolic conditions among Aboriginal and Torres Strait Islander young people.
    Med J Aust. 2019 Jan 18. doi: 10.5694/mja2.13002.
    PubMed     Text format    


    Nature

  69. WIMMER RA, Leopoldi A, Aichinger M, Wick N, et al
    Human blood vessel organoids as a model of diabetic vasculopathy.
    Nature. 2019;565:505-510.
    PubMed     Text format     Abstract available


    Nutr Metab (Lond)

  70. WANG Y, Sun L, Lin X, Yuan JM, et al
    Retinol binding protein 4 and risk of type 2 diabetes in Singapore Chinese men and women: a nested case-control study.
    Nutr Metab (Lond). 2019;16:3.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  71. YAZAR A, Akin F, Akca OF, Eklioglu BS, et al
    The Effect of Attention Deficit/Hyperactivity Disorder and Other Psychiatric Disorders on the Treatment of Pediatric Diabetes Mellitus.
    Pediatr Diabetes. 2019 Jan 16. doi: 10.1111/pedi.12819.
    PubMed     Text format     Abstract available

  72. LIESE AD, Ma X, Reid L, Sutherland M, et al
    Health Care Access and Glycemic Control in Youth and Young Adults with Type 1 and Type 2 Diabetes in South Carolina.
    Pediatr Diabetes. 2019 Jan 22. doi: 10.1111/pedi.12822.
    PubMed     Text format     Abstract available

  73. MIRANDA-LORA AL, Molina-Diaz M, Cruz M, Sanchez-Urbina R, et al
    Genetic polymorphisms associated with pediatric-onset type 2 diabetes: A family-based transmission disequilibrium test and case-control study.
    Pediatr Diabetes. 2019 Jan 16. doi: 10.1111/pedi.12818.
    PubMed     Text format     Abstract available

  74. CONNAN V, Marcon MA, Mahmud FH, Assor E, et al
    Online education for gluten-free diet teaching: Development and usability testing of an e-learning module for children with concurrent celiac disease and type 1 diabetes.
    Pediatr Diabetes. 2019 Jan 16. doi: 10.1111/pedi.12815.
    PubMed     Text format     Abstract available

  75. THALANGE N, Deeb L, Klingensmith G, Franco DR, et al
    The Rate of Hyperglycemia and Ketosis With Insulin Degludec-Based Treatment Compared With Insulin Detemir in Pediatric Patients With Type 1 Diabetes: An Analysis of Data From Two Randomized Trials.
    Pediatr Diabetes. 2019 Jan 22. doi: 10.1111/pedi.12821.
    PubMed     Text format     Abstract available


    PLoS One

  76. SOMEYA Y, Tamura Y, Kohmura Y, Aoki K, et al
    A body mass index over 22 kg/m2 at college age is a risk factor for future diabetes in Japanese men.
    PLoS One. 2019;14:e0211067.
    PubMed     Text format     Abstract available

  77. HJELMGREN O, Stromberg U, Gellerman K, Thurin A, et al
    Does retinopathy predict stroke recurrence in type 2 diabetes patients: A retrospective study?
    PLoS One. 2019;14:e0210832.
    PubMed     Text format     Abstract available

  78. TROTTA MC, Maisto R, Guida F, Boccella S, et al
    The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.
    PLoS One. 2019;14:e0211005.
    PubMed     Text format     Abstract available

  79. KIM JH, Park EC
    Can diabetes patients seeking a second hospital get better care? Results from nested case-control study.
    PLoS One. 2019;14:e0210809.
    PubMed     Text format     Abstract available

  80. LILLEGRAVEN S, Greenberg JD, Reed GW, Saunders K, et al
    Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
    PLoS One. 2019;14:e0210459.
    PubMed     Text format     Abstract available


    Retina

  81. BONNIN S, Dupas B, Lavia C, Erginay A, et al
    ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY CAN IMPROVE DIABETIC RETINOPATHY SCORE WITHOUT CHANGE IN RETINAL PERFUSION.
    Retina. 2019 Jan 3. doi: 10.1097/IAE.0000000000002422.
    PubMed     Text format     Abstract available


    WMJ

  82. AZAM L, Meurer J, Nelson D, Asan O, et al
    Cultural and Social Challenges of Diabetes Self-Management Education Through Physicians' Voices.
    WMJ. 2018;117:219-223.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: